thesis presentation10

Upload: janinefigueroa

Post on 04-Apr-2018

228 views

Category:

Documents


0 download

TRANSCRIPT

  • 7/31/2019 THESIS Presentation10

    1/34

    DETERMINATION OF LOW DENSITYLIPOPROTEIN (LDL) LOWERING

    ACTIVITY OF FORMULATED

    CAPSULE FROM RED YEAST(Monascus purpureus) RICE INHYPERLIPIDEMIC RABBITS

    Alcarde,Gerallene Mae F.

    Sinoy,Alejli Anne C.

  • 7/31/2019 THESIS Presentation10

    2/34

    CHAPTER 1

    INTRODUCTION

  • 7/31/2019 THESIS Presentation10

    3/34

    The Problem and Its setting

    WHO STATISTICS

    30 % of all global deaths is due to

    CARDIOVASCULAR

    DISEASES

  • 7/31/2019 THESIS Presentation10

    4/34

    DEPARTMENT OF HEALTH

    TOP LEADING CAUSE OF MORTALITY

  • 7/31/2019 THESIS Presentation10

    5/34

  • 7/31/2019 THESIS Presentation10

    6/34

  • 7/31/2019 THESIS Presentation10

    7/34

  • 7/31/2019 THESIS Presentation10

    8/34

    Monacolin K

    LACTONE FORM HYDROXY ACID

  • 7/31/2019 THESIS Presentation10

    9/34

    Dr. Dulce Florespresented a studyabout red yeastrice

  • 7/31/2019 THESIS Presentation10

    10/34

    STATEMENT OF THE PROBLEM

    1. What is the Approximate Effective Dose (AED)of the Red Yeast Rice formulated capsule inrabbits?

    2. What is the Effective Dose (ED50) of the RedYeast Rice formulated capsules inhyperlipidemic rabbits?

    3. Is there a significant difference in the LDL levelof rabbits when treated with formulatedcapsule of Red yeast rice, Lovastatin Tablet andPlacebo capsule?

  • 7/31/2019 THESIS Presentation10

    11/34

    NULL HYPOTHESIS

    There is no significant difference on the LDLlevels of the hyperlipidemic rabbits treatedwith formulated capsule of Red yeast ricecompared with Lovastatin tablet and Placebocapsule .

  • 7/31/2019 THESIS Presentation10

    12/34

    THEORETICAL FRAMEWORK

    Red Yeast rice may lower totalcholesterol by 13-26% and LDL by 21-

    33%-Wang et al (1997), Heber et al

    (1999), Qin et al (1999), Rippe et al (1999) , Keithley et al (2002)

  • 7/31/2019 THESIS Presentation10

    13/34

    RYR and therapeutic lifestyle change decreaseLDL cholesterol level without increasing CPK in

    pain levels and may be a treatment option fordyslipidemic patients who cannot toleratestatin-theraphy

    (Becker , D., Gordon , R., Halbert, S., French , B.,Morris, P., & Rader , D. (2009, June 16). Redyeast rice for dyslipidemia in statin-intolerant

    patients: a randomized trial. . US National Library of Medicine )

  • 7/31/2019 THESIS Presentation10

    14/34

    RYRsignificantly reduces totalcholesterol, LDL cholesterol andtotal triacylglycerols concentrationscompared with placebo (Heber etal)

  • 7/31/2019 THESIS Presentation10

    15/34

    CONCEPTUAL FRAMEWORK

    INDEPENDENTVARIABLEFormulated Capsule of

    Red Yeast RiceLovastatin Tablet(positive control)

    Placebo( negative control)

    DEPENDENTVARIABLE

    LDL level (mmol/L)in hyperlipidemicrabbits

  • 7/31/2019 THESIS Presentation10

    16/34

  • 7/31/2019 THESIS Presentation10

    17/34

  • 7/31/2019 THESIS Presentation10

    18/34

    To theResearchers

    Prove that red yeast rice can

    lower the LDL in hyperlipidemicrabbits

  • 7/31/2019 THESIS Presentation10

    19/34

    Mortalitycases of CVDS

  • 7/31/2019 THESIS Presentation10

    20/34

    Emphasize the effortsmade by the Food andTechnology Department toprovide cost-effectiveproducts for poorhyperlipidemic Filipinos

  • 7/31/2019 THESIS Presentation10

    21/34

    To the Philippine Pharmaceutical Society

    Help in the production andmarketing of cost-effective drug for hyperlipidemic patients especiallythe poor .

  • 7/31/2019 THESIS Presentation10

    22/34

    SCOPE AND DELIMITATION

  • 7/31/2019 THESIS Presentation10

    23/34

    The coverage of the study will focus on the

    determination of LDL lowering activity levels of theRed Yeast rice and determination of its AED and

    ED50 in treating hyperlipidemic rabbits

  • 7/31/2019 THESIS Presentation10

    24/34

    Red Yeast Rice : UP Mindanao Food Tech Dept. Lovastatin : commercially available

    Experimentation : University of the ImmaculateConception Test Animals (Rabbits) : Rabbit Breeding Farm

    in Tugbok District

  • 7/31/2019 THESIS Presentation10

    25/34

    PARAMETERS IN MEASURING LDL

    Monitoring of :1. Mortality2. body weight

    3. food consumption4. water intake5. measurement of LDL levels

  • 7/31/2019 THESIS Presentation10

    26/34

    Definition of Terms

  • 7/31/2019 THESIS Presentation10

    27/34

    APPROXIMATE EFFECTIVE DOSE.

    Approximate Effective Dose is the

    estimated dose of a drug to produce adesired response.

  • 7/31/2019 THESIS Presentation10

    28/34

    CHOLESTEROL Cholesterol is a sterol and a lipid found in

    the cell membranes of all body tissues.

  • 7/31/2019 THESIS Presentation10

    29/34

    Effective Dose (ED50) Effective dose is the dose of a drug

    predicted to produce a characteristic effectin 50 % of the subjects to whom the doseis given.

  • 7/31/2019 THESIS Presentation10

    30/34

    Hyperlipidemia Hyperlipidemia is an increase in the

    amount of fat (such as cholesterol andtriglycerides) in the blood. Theseincreases can lead to heart disease andpancreatitis.

  • 7/31/2019 THESIS Presentation10

    31/34

    Lipid Profile Lipid Profile is a group of test that

    indicates your risk of heart disease. Thelipid profile tests levels of cholesterol, HDLcholesterol, LDL cholesterol andtriglycerides .

  • 7/31/2019 THESIS Presentation10

    32/34

    Lovastatin Lovastatin is a widely used statin drug, a

    cholesterol lowering agent; anindependent variable used as a positivecontrol in the study.

  • 7/31/2019 THESIS Presentation10

    33/34

    LDL (Low Density Lipoprotein)

    Low Density Lipoprotein refers to a classand range of lipoprotein particles, varyingin their size (18-25 nm in diameter) andcontents, which carry cholesterol in theblood and around the body, for use bycells.

  • 7/31/2019 THESIS Presentation10

    34/34

    Placebo Placebo is an independent variable which

    serves as negative control.